First Choice | Second Choice | Third Choice | |
---|---|---|---|
All Respondents | |||
All (326) | Indication for use | Assistance with follow-up | Patient involvement |
Age | |||
<49 years (118) | Indication for use | Assistance with follow-up | Information exchange with all pharmacies |
50–59 years (120) | Indication for use | Assistance with follow-up | Patient involvement |
≥60 years (83) | Indication for use | Patient involvement | Assistance with follow-up |
Gender | |||
Male (151) | Indication for use | Assistance with follow-up | Patient involvement |
Female (165) | Assistance with follow-up | Indication for use | Patient involvement |
Race | |||
White (235) | Assistance with follow-up | Indication for use | Patient involvement |
Non-White (81) | Indication for use | Patient involvement | Clinical decision support |
Provider type | |||
Physician (243) | Indication for use | Assistance with follow-up | Patient involvement |
Nurse Practitioner or Physician Assistant (53) | Indication for use | Assistance with follow-up | Patient involvement |
Clinical Pharmacy Specialist (30) | Indication for use | Information exchange with all pharmacies | Improved information exchange with providers located at community facilities |
Number of clinic sessions per week | |||
≤7 (148) | Assistance with follow-up | Indication for use | Patient involvement |
8–10 (167) | Indication for use | Patient involvement | Assistance with follow-up |
Number of years working in VA | |||
≤4 (94) | Indication for use | Information exchange with all pharmacies | Assistance with follow-up |
5–9 (80) | Assistance with follow-up | Indication for use | Patient involvement |
≥10 (146) | Indication for use | Assistance with follow-up | Patient involvement |
Prior experience working in a non-VA setting | |||
Yes (250) | Indication for use | Assistance with follow-up | Patient involvement |
No (69) | Assistance with follow-up | Patient involvement | Indication for use |
Self-rated comfort with medication discontinuation (0–10 scale) | |||
Low, 0–6 (83) | Assistance with follow-up | Indication for use | Information exchange with all pharmacies |
Medium, 7–8 (126) | Assistance with follow-up | Indication for use | Patient involvement |
High 9–10 (108) | Indication for use | Assistance with follow-up | Information exchange with all pharmacies |
Beliefs about medication overuse | |||
Neutral/disagree/strongly disagree (288) | Indication for use | Assistance with follow-up | Patient involvement |
Agree/strongly agree (38) | Patient involvement | Indication for use | Information exchange with all pharmacies |
Perceptions of patients’ ability to manage their own health | |||
Less (223) | Indication for use | Assistance with follow-up | Patient involvement |
More (101) | Indication for use | Patient involvement | Assistance with follow-up |
Frequency of experiencing uncertainty about the indication for a patient’s medication | |||
Never/Rarely (83) | Indication for use | Assistance with follow-up | Information exchange with all pharmacies |
Sometimes (173) | Assistance with follow-up | Indication for use | Patient involvement |
Often/Usually (68) | Indication for use | Patient involvement | Assistance with follow-up |
Experience with discontinuing medications initiated by other providers | |||
Never/rarely (46) | Patient involvement | Indication for use | Clinical decision support |
Sometimes (271) | Indication for use | Assistance with follow-up | Patient involvement |
Often/usually (8) | Assistance with follow-up | Indication for use | Patient involvement |
Experience with patient activation | |||
Low (117) | Indication for use | Assistance with follow-up | Information exchange with all pharmacies |
Medium (108) | Assistance with follow-up | Indication for use | Patient involvement |
High (97) | Patient involvement | Indication for use | Assistance with follow-up |